New drug aims to shrink dangerous heart plaque

NCT ID NCT07301034

Recruiting now Disease control Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an experimental drug called ziltivekimab can reduce the fatty plaque buildup in heart arteries of people who recently had a heart attack. About 332 participants will be randomly assigned to receive either the drug or a placebo (dummy treatment) for 15 months. Doctors will use advanced imaging to see if the drug actually shrinks the plaque and makes it less dangerous.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AOU Maggiore della Carità di Novara - Dipartimento Toraco-Cardio-Vascolare - SCDU Cardiologia
NOT_YET_RECRUITING

Novara, 28100, Italy
Aalborg Universitetshospital Hjertemedicinsk Afdeling
NOT_YET_RECRUITING

Gistrup, 9260, Denmark
Azienda Ospedaliera San Giovanni Addolorata
NOT_YET_RECRUITING

Rome, Lazio, 00184, Italy
Azienda Ospedaliera Universitaria San Luigi Gonzaga - S.C.D.O. Microcitemie e malattie rare ematologiche
NOT_YET_RECRUITING

Orbassano, 10043, Italy
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII
NOT_YET_RECRUITING

Bergamo, Lombardy, 24127, Italy
DAI Scienze Mediche - UOC Endocrinologia
NOT_YET_RECRUITING

Messina, Sicily, 98124, Italy
Erasmus MC
NOT_YET_RECRUITING

Rotterdam, 3015 GD, Netherlands
Fondazione Policlinico Universitario Agostino Gemelli IRCS
NOT_YET_RECRUITING

Rome, 00168, Italy
HUG-Service de Cardiologie
NOT_YET_RECRUITING

Geneva, 1205, Switzerland
Hospital Universitario Marqués de Valdecilla
NOT_YET_RECRUITING

Santander, 39008, Spain
Hospital Universitario de la Princesa
NOT_YET_RECRUITING

Madrid, 28006, Spain
IRCCS Policlinico San Donato
NOT_YET_RECRUITING

San Donato Milanese, 20097, Italy
Inselspital-Universitätsklinik für Kardiologie
RECRUITING

Bern, 3010, Switzerland
LUKS-Herzzentrum
RECRUITING

Lucerne, 6000, Switzerland
Medizinische Universität Wien
NOT_YET_RECRUITING

Vienna, 1090, Austria
Ospedale Policlinico San Martino
NOT_YET_RECRUITING

Genova, 16132, Italy
Presidio Ospedaliero di Rivoli
NOT_YET_RECRUITING

Rivoli, To, 10098, Italy
Radboudumc
NOT_YET_RECRUITING

Nijmegen, 6525 GA, Netherlands
Rigshospitalet - Kardiologisk Forskningsenhed
NOT_YET_RECRUITING

København Ø, 2100, Denmark
Universitäres Herzzentrum
RECRUITING

Basel, 4031, Switzerland

Conditions

Explore the condition pages connected to this study.

MYOCARDIAL INFARCTION